Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site
View ORCID ProfileZsὁfia Iglὁi, Jans Velzing, Janko van Beek, David van de Vijver, Georgina Aron, Roel Ensing, Kimberley Benschop, Wanda Han, Timo Boelsums, Marion Koopmans, Corine Geurtsvankessel, Richard Molenkamp
doi: https://doi.org/10.1101/2020.11.18.20234104
Zsὁfia Iglὁi
1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
Jans Velzing
1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
Janko van Beek
1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
David van de Vijver
1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
Georgina Aron
1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
Roel Ensing
2Public Health Service Rotterdam-Rijnmond, Rotterdam, The Netherlands
Kimberley Benschop
3Centre for infectious Disease Control (Cib), National Public Health Institute (RIVM), Bilthoven, The Netherlands
Wanda Han
3Centre for infectious Disease Control (Cib), National Public Health Institute (RIVM), Bilthoven, The Netherlands
Timo Boelsums
2Public Health Service Rotterdam-Rijnmond, Rotterdam, The Netherlands
Marion Koopmans
1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
Corine Geurtsvankessel
1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
Richard Molenkamp
1Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
Data Availability
all data is available
Posted November 20, 2020.
Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site
Zsὁfia Iglὁi, Jans Velzing, Janko van Beek, David van de Vijver, Georgina Aron, Roel Ensing, Kimberley Benschop, Wanda Han, Timo Boelsums, Marion Koopmans, Corine Geurtsvankessel, Richard Molenkamp
medRxiv 2020.11.18.20234104; doi: https://doi.org/10.1101/2020.11.18.20234104
Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site
Zsὁfia Iglὁi, Jans Velzing, Janko van Beek, David van de Vijver, Georgina Aron, Roel Ensing, Kimberley Benschop, Wanda Han, Timo Boelsums, Marion Koopmans, Corine Geurtsvankessel, Richard Molenkamp
medRxiv 2020.11.18.20234104; doi: https://doi.org/10.1101/2020.11.18.20234104
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (696)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12508)
- Forensic Medicine (10)
- Gastroenterology (797)
- Genetic and Genomic Medicine (4375)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2821)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (890)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4140)
- Nursing (219)
- Nutrition (614)
- Oncology (2179)
- Ophthalmology (620)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (261)
- Palliative Medicine (81)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6726)
- Radiology and Imaging (1478)
- Respiratory Medicine (893)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)